glp-1 incretin effect A Tale of Two Incretins The incretin effect in healthy

The Mounjaro Difference: Dual Action, Dual Impact Mounjaro and Zepbound (both tirzepatide) deserve special mention because theyre not just GLP-1 receptor agoniststhey also target GIP (glucose-dependent insulinotropic polypeptide) receptors

Knudsen was also highly aware of the desperation of obesity specialists to find a way to help their patients whose numbers were rapidly increasing and therefore at higher risk of diabetes, cardiovascular disease and other conditions like osteoarthritis, obstructive sleep apnea, cancer, and back pain

The goal isn't to force-feed yourself

Manufacturer patient assistance programs often provide substantial savings for qualifying patients